Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 820543, 6 pages
http://dx.doi.org/10.1155/2015/820543
Research Article

Systemic Chemotherapy Is Modulated by Platelet-Activating Factor-Receptor Agonists

1Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA
2Department of Dermatology, Indiana University School of Medicine, Indianapolis, IN 46202, USA
3Department of Pharmacology and Toxicology, Wright State University, Dayton, OH 45435, USA
4Dayton Veterans Administration Medical Center, Dayton, OH 45435, USA

Received 26 January 2015; Revised 18 March 2015; Accepted 20 March 2015

Academic Editor: Yona Keisari

Copyright © 2015 Ravi P. Sahu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. J. Miller and M. C. Mihm Jr., “Melanoma,” The New England Journal of Medicine, vol. 355, no. 1, pp. 51–65, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Howlader, A. M. Noone, M. Krapcho et al., SEER Cancer Statistics Review, 1975–2010, National Cancer Institute, Bethesda, Md, USA, 2012, http://seer.cancer.gov/csr/1975_2010/, http://seer.cancer.gov/statfacts/html/melan.html.
  3. J. Treisman and N. Garlie, “Systemic therapy for cutaneous melanoma,” Clinics in Plastic Surgery, vol. 37, no. 1, pp. 127–146, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. M. B. Lens and T. G. Eisen, “Systemic chemotherapy in the treatment of malignant melanoma,” Expert Opinion on Pharmacotherapy, vol. 4, no. 12, pp. 2205–2211, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. W. J. Hwu, “New approaches in the treatment of metastatic melanoma: thalidomide and temozolomide,” Oncology, vol. 12, supplement 13, pp. 25–28, 2000. View at Google Scholar
  6. C. K. Kissel, D. Schadendorf, and H. Röckmann, “The altered apoptotic pathways in cisplatin and etoposide-resistant melanoma cells are drug specific,” Melanoma Research, vol. 16, no. 6, pp. 527–535, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Helmbach, M. A. Kern, E. Rossmann et al., “Drug resistance towards etoposide and cisplatin in human melanoma cells is associated with drug-dependent apoptosis deficiency,” Journal of Investigative Dermatology, vol. 118, no. 6, pp. 923–932, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. A. R. Bowen, A. N. Hanks, S. M. Allen, A. Alexander, M. J. Diedrich, and D. Grossman, “Apoptosis regulators and responses in human melanocytic and keratinocytic cells,” Journal of Investigative Dermatology, vol. 120, no. 1, pp. 48–55, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Grottke, K. Mantwill, M. Dietel, D. Schadendorf, and H. Lage, “Identification of differentially expressed genes in human melanoma cells with acquired resistance to various antineoplastic drugs,” International Journal of Cancer, vol. 88, no. 4, pp. 535–546, 2000. View at Google Scholar
  10. K. A. Conklin, “Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness,” Integrative Cancer Therapies, vol. 3, no. 4, pp. 294–300, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Arora, A. Bhardwaj, S. Singh et al., “An undesired effect of chemotherapy: gemcitabine promotes pancreatic cancer cell invasiveness through reactive oxygen species-dependent, nuclear factor κB- and hypoxia-inducible factor 1α-mediated up-regulation of CXCR4,” The Journal of Biological Chemistry, vol. 288, no. 29, pp. 21197–21207, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Qu, T. Lin, Z. Wang et al., “Reactive oxygen species generation is essential for cisplatininduced accelerated senescence in hepatocellular carcinoma,” Frontiers of Medicine in China, vol. 8, no. 2, pp. 227–235, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. J. P. Walterscheid, S. E. Ullrich, and D. X. Nghiem, “Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression,” Journal of Experimental Medicine, vol. 195, no. 2, pp. 171–179, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. J. B. Travers, D. Berry, Y. Yao, Q. Yi, R. L. Konger, and J. B. Travers, “Ultraviolet B radiation of human skin generates platelet-activating factor receptor agonists,” Photochemistry and Photobiology, vol. 86, no. 4, pp. 949–954, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. R. L. Konger, G. K. Marathe, Y. Yao, Q. Zhang, and J. B. Travers, “Oxidized glycerophosphocholines as biologically active mediators for ultraviolet radiation-mediated effects,” Prostaglandins and Other Lipid Mediators, vol. 87, no. 1-4, pp. 1–8, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Yao, J. E. Wolverton, Q. Zhang et al., “Ultraviolet B radiation generated platelet-activating factor receptor agonist formation involves EGF-R-mediated reactive oxygen species,” The Journal of Immunology, vol. 182, no. 5, pp. 2842–2848, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. R. P. Sahu, I. Petrache, M. J. van Demark et al., “Cigarette smoke exposure inhibits contact hypersensitivity via the generation of platelet-activating factor agonists,” The Journal of Immunology, vol. 190, no. 5, pp. 2447–2454, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. D. M. Stafforini, T. M. McIntyre, G. A. Zimmerman, and S. M. Prescott, “Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes,” Critical Reviews in Clinical Laboratory Sciences, vol. 40, no. 6, pp. 643–672, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. N. B. Countryman, Y. Pei, Q. Yi, D. F. Spandau, and J. B. Travers, “Evidence for involvement of the epidermal platelet activating factor receptor in ultraviolet-B-radiation induced interleukin-8 production,” Journal of Investigative Dermatology, vol. 115, no. 2, pp. 267–272, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. J. B. Travers, J. C. Huff, M. Rola-Pleszczynski, E. W. Gelfand, J. G. Morelli, and R. C. Murphy, “Identification of functional platelet-activating factor receptors on human keratinocytes,” Journal of Investigative Dermatology, vol. 105, no. 6, pp. 816–823, 1995. View at Publisher · View at Google Scholar · View at Scopus
  21. R. P. Sahu, Y. Yao, R. L. Konger, and J. B. Travers, “Platelet-activating factor does not mediate uvb-induced local immune suppression,” Photochemistry and Photobiology, vol. 88, no. 2, pp. 490–493, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. S. E. Ullrich, “Mechanisms underlying UV-induced immune suppression,” Mutation Research, vol. 571, no. 1-2, pp. 185–205, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. Q. Zhang, Y. Yao, R. L. Konger et al., “UVB radiation-mediated inhibition of contact hypersensitivity reactions is dependent on the platelet-activating factor system,” Journal of Investigative Dermatology, vol. 128, no. 7, pp. 1780–1787, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. J. B. Travers, H. J. Edenberg, Q. Zhang et al., “Augmentation of UVB radiation-mediated early gene expression by the epidermal platelet-activating factor receptor,” Journal of Investigative Dermatology, vol. 128, no. 2, pp. 455–460, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. R. P. Sahu, M. J. Turner, S. C. Dasilva et al., “The environmental stressor ultraviolet B radiation inhibits murine antitumor immunity through its ability to generate platelet-activating factor agonists,” Carcinogenesis, vol. 33, no. 7, pp. 1360–1367, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. P. C. Hackler, S. Reuss, R. L. Konger, J. B. Travers, and R. P. Sahu, “Systemic platelet-activating factor receptor activation augments experimental lung tumor growth and metastasis,” Cancer Growth and Metastasis, vol. 7, pp. 27–32, 2014. View at Publisher · View at Google Scholar
  27. V. O. Melnikova, G. J. Villares, and M. Bar-Eli, “Emerging roles of PAR-1 and PAFR in melanoma metastasis,” Cancer Microenvironment, vol. 1, no. 1, pp. 103–111, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. S. I. de Oliveira, L. N. S. Andrade, A. C. Onuchic et al., “Platelet-activating factor receptor (PAF-R)-dependent pathways control tumour growth and tumour response to chemotherapy,” BMC Cancer, vol. 10, article 200, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. R. P. Sahu, J. A. Ocana, K. A. Harrison et al., “Chemotherapeutic agents subvert tumor immunity by generating agonists of platelet-activating factor,” Cancer Research, vol. 74, no. 23, pp. 7069–7078, 2014. View at Publisher · View at Google Scholar
  30. M. H. Giles and B. J. Coventry, “Isolated limb infusion chemotherapy for melanoma: an overview of early experience at the Adelaide Melanoma Unit,” Cancer Management and Research, vol. 5, no. 1, pp. 243–249, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Cai, T. R. Bagby, and M. L. Forrest, “Development of regional chemotherapies: feasibility, safety and efficacy in clinical use and preclinical studies,” Therapeutic Delivery, vol. 2, no. 11, pp. 1467–1484, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Taymouri and J. Varshosaz, “The recent progresses on the improved therapy of melanoma by novel drug delivery systems,” Current Drug Targets, vol. 15, no. 9, pp. 829–842, 2014. View at Publisher · View at Google Scholar
  33. M. Ferracini, R. P. Sahu, K. A. Harrison et al., “Topical photodynamic therapy induces systemic immunosuppression via generation of platelet-activating factor receptor ligands,” Journal of Investigative Dermatology, vol. 135, no. 1, pp. 321–323, 2014. View at Publisher · View at Google Scholar
  34. K. H. Seo, H.-M. Ko, H.-A. Kim et al., “Platelet-activating factor induces up-regulation of antiapoptotic factors in a melanoma cell line through nuclear factor-κB activation,” Cancer Research, vol. 66, no. 9, pp. 4681–4686, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. A. C. Onuchic, C. M. L. MacHado, R. F. Saito, F. J. Rios, S. Jancar, and R. Chammas, “Expression of PAFR as part of a prosurvival response to chemotherapy: a novel target for combination therapy in melanoma,” Mediators of Inflammation, vol. 2012, Article ID 175408, 6 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus